AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Appropriations History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Appropriations | ₹24,446 Cr | ₹22,785 Cr | ₹20,377 Cr | ₹15,244 Cr | ₹12,576 Cr |
What is the latest Appropriations of AUROBINDO PHARMA ?
Year | Appropriations |
---|---|
Mar2024 | ₹24,446 Cr |
Mar2023 | ₹22,785 Cr |
Mar2022 | ₹20,377 Cr |
Mar2021 | ₹15,244 Cr |
Mar2020 | ₹12,576 Cr |
How is Appropriations of AUROBINDO PHARMA Trending?
Years | Appropriations | % Change | |
---|---|---|---|
Mar2024 | ₹24,446 Cr | 7.29 | |
Mar2023 | ₹22,785 Cr | 11.82 | |
Mar2022 | ₹20,377 Cr | 33.68 | |
Mar2021 | ₹15,244 Cr | 21.21 | |
Mar2020 | ₹12,576 Cr | - |
Compare Appropriations of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹64,297.5 Cr | -4.4% | -8% | -8.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -4.4% |
-8% |
-8.3% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses